ProfileGDS4718 / 205661_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 66% 63% 71% 62% 79% 79% 70% 67% 70% 72% 64% 75% 76% 77% 69% 71% 71% 81% 57% 73% 70% 69% 74% 67% 80% 69% 61% 65% 68% 73% 78% 61% 70% 77% 78% 70% 68% 67% 66% 73% 76% 71% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9460771
GSM549102patient 115, normal, homogenized [OPG study]6.5753766
GSM549104patient 119, normal, homogenized [OPG study]6.3724163
GSM549108patient 138, normal, homogenized [OPG study]6.9507171
GSM549119patient 077, normal, homogenized [OPG study]6.2844762
GSM549133patient 032, cancer, homogenized [OPG study]7.8409979
GSM549139patient 042, cancer, homogenized [OPG study]7.7327679
GSM549099patient 107, normal, homogenized [OPG study]6.8274270
GSM549109patient 139, normal, homogenized [OPG study]6.6571867
GSM549110patient 046, normal, homogenized [OPG study]6.8015270
GSM549114patient 063, normal, homogenized [OPG study]7.0842772
GSM549122patient 082, normal, homogenized [OPG study]6.3977764
GSM549134patient 033, cancer, homogenized [OPG study]7.315875
GSM549136patient 036, cancer, homogenized [OPG study]7.5328276
GSM549140patient 044, cancer, homogenized [OPG study]7.607477
GSM549111patient 047, normal, homogenized [OPG study]6.8394269
GSM549113patient 057, normal, homogenized [OPG study]7.0159671
GSM549132patient 031, cancer, homogenized [OPG study]6.9909571
GSM549137patient 038, cancer, homogenized [OPG study]7.9897481
GSM549142patient 047, cancer, homogenized [OPG study]6.0177357
GSM549100patient 110, normal, homogenized [OPG study]7.0718373
GSM549107patient 135, normal, homogenized [OPG study]6.8318270
GSM549115patient 068, normal, homogenized [OPG study]6.7925969
GSM549116patient 072, normal, homogenized [OPG study]7.2713374
GSM549120patient 078, normal, homogenized [OPG study]6.6369367
GSM549131patient 030, cancer, homogenized [OPG study]8.0017380
GSM549118patient 074, normal, homogenized [OPG study]6.782969
GSM549129patient 027, cancer, homogenized [OPG study]6.257461
GSM549123patient 088, normal, homogenized [OPG study]6.4800465
GSM549124patient 006, cancer, homogenized [OPG study]6.6605968
GSM549126patient 015, cancer, homogenized [OPG study]7.1509573
GSM549128patient 025, cancer, homogenized [OPG study]7.7225378
GSM549103patient 117, normal, homogenized [OPG study]6.2169361
GSM549117patient 073, normal, homogenized [OPG study]6.8252570
GSM549138patient 041, cancer, homogenized [OPG study]7.5307977
GSM549141patient 045, cancer, homogenized [OPG study]7.8159678
GSM549130patient 028, cancer, homogenized [OPG study]6.8735370
GSM549101patient 111, normal, homogenized [OPG study]6.6971368
GSM549105patient 128, normal, homogenized [OPG study]6.6634267
GSM549106patient 134, normal, homogenized [OPG study]6.5808166
GSM549112patient 048, normal, homogenized [OPG study]7.1647173
GSM549125patient 011, cancer, homogenized [OPG study]7.4319476
GSM549127patient 024, cancer, homogenized [OPG study]7.0115671
GSM549135patient 035, cancer, homogenized [OPG study]7.8398179